ZX008-1800

Drug Zogenix Inc.
Total Payments
$37,785
Transactions
19
Doctors
2
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2020 $37,785 19 2

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $37,785 19 100.0%

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
ZX008 Expanded Access Protocol - Dravet Syndrome Treatment Plan Zogenix Inc. $37,785 2

Top Doctors Receiving Payments for ZX008-1800

Doctor Specialty Location Total Records
Unknown — Rochester, MN $31,035 14
, M.D Pediatric Cardiology Boston, MA $5,850 4
, MD Pediatric Cardiology Los Angeles, CA $900.00 1

Manufacturing Companies

Product Information

  • Type Drug
  • Total Payments $37,785
  • Total Doctors 2
  • Transactions 19

About ZX008-1800

ZX008-1800 is a drug associated with $37,785 in payments to 2 healthcare providers, recorded across 19 transactions in the CMS Open Payments database. The primary manufacturer is Zogenix Inc..

Payment data is available from 2020 to 2020. In 2020, $37,785 was paid across 19 transactions to 2 doctors.

The most common payment nature for ZX008-1800 is "Unspecified" ($37,785, 100.0% of total).

ZX008-1800 is associated with 1 research study, including "ZX008 Expanded Access Protocol - Dravet Syndrome Treatment Plan" ($37,785).